SEC Form D filing

Caldera Therapeutics, Inc., 2026-01-21

An SEC Form D private-offering notice from Cambridge, MA, a $37,500,000 filer-stated offering target in Biotech. Filed 2026-01-21. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Caldera Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical stage biotech developing CLD-423, a bispecific antibody targeting IL-23p19 and TL1A for inflammatory bowel disease

Filed 2026-01-21Filed to raise $37,500,000First money in 2026-01-08Raised so far $37,500,000HQ (as filed) Cambridge, MASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified calderatx.com↗Named in the filing 5 executives & directors
Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source